CNS Pharmaceuticals Statistics
Total Valuation
CNSP has a market cap or net worth of $4.63 million. The enterprise value is -$7.38 million.
Important Dates
The next estimated earnings date is Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CNSP has 574,580 shares outstanding.
| Current Share Class | 574,580 |
| Shares Outstanding | 574,580 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +62.89% |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | 1.52% |
| Float | 525,998 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.31 |
| P/TBV Ratio | 0.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.22, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.22 |
| Quick Ratio | 8.77 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,009.79 |
Financial Efficiency
Return on equity (ROE) is -350.08% and return on invested capital (ROIC) is -214.51%.
| Return on Equity (ROE) | -350.08% |
| Return on Assets (ROA) | -114.68% |
| Return on Invested Capital (ROIC) | -214.51% |
| Return on Capital Employed (ROCE) | -118.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.09M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.84% in the last 52 weeks. The beta is 0.74, so CNSP's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -89.84% |
| 50-Day Moving Average | 8.06 |
| 200-Day Moving Average | 19.94 |
| Relative Strength Index (RSI) | 41.10 |
| Average Volume (20 Days) | 26,229 |
Short Selling Information
The latest short interest is 45,735, so 7.96% of the outstanding shares have been sold short.
| Short Interest | 45,735 |
| Short Previous Month | 41,771 |
| Short % of Shares Out | 7.96% |
| Short % of Float | 8.69% |
| Short Ratio (days to cover) | 0.90 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.58M |
| Pretax Income | -15.46M |
| Net Income | -15.46M |
| EBITDA | -15.57M |
| EBIT | -15.58M |
| Earnings Per Share (EPS) | -$85.41 |
Full Income Statement Balance Sheet
The company has $12.13 million in cash and $121,767 in debt, giving a net cash position of $12.01 million or $20.90 per share.
| Cash & Cash Equivalents | 12.13M |
| Total Debt | 121,767 |
| Net Cash | 12.01M |
| Net Cash Per Share | $20.90 |
| Equity (Book Value) | 13.12M |
| Book Value Per Share | 26.02 |
| Working Capital | 12.75M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$20.86 million and capital expenditures -$4,188, giving a free cash flow of -$20.86 million.
| Operating Cash Flow | -20.86M |
| Capital Expenditures | -4,188 |
| Free Cash Flow | -20.86M |
| FCF Per Share | -$36.31 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -333.80% |
| FCF Yield | -450.44% |
Analyst Forecast
The average price target for CNSP is $20.00, which is 148.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.00 |
| Price Target Difference | 148.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -51.72% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 22, 2025. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jul 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |